FibroBiologics (FBLG) AGM 2026 summary

Opening remarks and agenda

• Meeting commenced with introductions of board members and executive team, noting Stacy Coen's departure from the board after five years of service.

• The agenda included four formal proposals and a Q&A session for stockholders.

Board and executive committee updates

• Stacy Coen stepped down from the board at the conclusion of the meeting, with appreciation expressed for her contributions.

Shareholder proposals

• Four proposals were presented: election of a Class III director, ratification of the audit firm, approval of share issuances related to warrants, and approval of the 2026 Equity and Incentive Compensation Plan.